BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 26681751)

  • 1. Angiotensinogen Exerts Effects Independent of Angiotensin II.
    Lu H; Wu C; Howatt DA; Balakrishnan A; Moorleghen JJ; Chen X; Zhao M; Graham MJ; Mullick AE; Crooke RM; Feldman DL; Cassis LA; Vander Kooi CW; Daugherty A
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):256-65. PubMed ID: 26681751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Amino Acids Proximate to the Renin Cleavage Site of Human Angiotensinogen Do Not Affect Blood Pressure and Atherosclerosis in Mice-Brief Report.
    Wu CH; Wu C; Howatt DA; Moorleghen JJ; Cassis LA; Daugherty A; Lu HS
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2108-2113. PubMed ID: 32640904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of angiotensinogen in hepatocytes markedly decreases blood pressure in lean and obese male mice.
    Yiannikouris F; Wang Y; Shoemaker R; Larian N; Thompson J; English VL; Charnigo R; Su W; Gong M; Cassis LA
    Hypertension; 2015 Oct; 66(4):836-42. PubMed ID: 26303292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of accelerated renal cystogenesis in Pkd1 mice by renin-angiotensin system blockade.
    Fitzgibbon WR; Dang Y; Bunni MA; Baicu CF; Zile MR; Mullick AE; Saigusa T
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F210-F218. PubMed ID: 29021226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cys18-Cys137 disulfide bond in mouse angiotensinogen does not affect AngII-dependent functions in vivo.
    Wu C; Xu Y; Lu H; Howatt DA; Balakrishnan A; Moorleghen JJ; Vander Kooi CW; Cassis LA; Wang JA; Daugherty A
    Hypertension; 2015 Apr; 65(4):800-5. PubMed ID: 25691624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report.
    Ye F; Wang Y; Wu C; Howatt DA; Wu CH; Balakrishnan A; Mullick AE; Graham MJ; Danser AHJ; Wang J; Daugherty A; Lu HS
    Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):150-155. PubMed ID: 30567480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Exploration of Conserved Sequences in the Distal Face of Angiotensinogen-Brief Report.
    Amioka N; Wu CH; Sawada H; Ito S; Pettey AC; Wu C; Moorleghen JJ; Howatt DA; Graf GA; Vander Kooi CW; Daugherty A; Lu HS
    Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1524-1532. PubMed ID: 37345525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and functions of angiotensinogen.
    Lu H; Cassis LA; Kooi CW; Daugherty A
    Hypertens Res; 2016 Jul; 39(7):492-500. PubMed ID: 26888118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice.
    Yiannikouris F; Gupte M; Putnam K; Thatcher S; Charnigo R; Rateri DL; Daugherty A; Cassis LA
    Hypertension; 2012 Dec; 60(6):1524-30. PubMed ID: 23108647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II increases adipose angiotensinogen expression.
    Lu H; Boustany-Kari CM; Daugherty A; Cassis LA
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1280-7. PubMed ID: 17213477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercholesterolemia Induced by a PCSK9 Gain-of-Function Mutation Augments Angiotensin II-Induced Abdominal Aortic Aneurysms in C57BL/6 Mice-Brief Report.
    Lu H; Howatt DA; Balakrishnan A; Graham MJ; Mullick AE; Daugherty A
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1753-7. PubMed ID: 27470509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensinogen in hepatocytes contributes to Western diet-induced liver steatosis.
    Tao XR; Rong JB; Lu HS; Daugherty A; Shi P; Ke CL; Zhang ZC; Xu YC; Wang JA
    J Lipid Res; 2019 Dec; 60(12):1983-1995. PubMed ID: 31604805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of plasma angiotensin II to normal levels by antisense oligodeoxynucleotides against liver angiotensinogen cannot completely attenuate vascular remodeling in spontaneously hypertensive rats.
    Sugano M; Tsuchida K; Sawada S; Makino N
    J Hypertens; 2000 Jun; 18(6):725-31. PubMed ID: 10872557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Pressure Lowering and Safety Improvements With Liver Angiotensinogen Inhibition in Models of Hypertension and Kidney Injury.
    Mullick AE; Yeh ST; Graham MJ; Engelhardt JA; Prakash TP; Crooke RM
    Hypertension; 2017 Sep; 70(3):566-576. PubMed ID: 28716988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation.
    Matsusaka T; Niimura F; Pastan I; Shintani A; Nishiyama A; Ichikawa I
    Kidney Int; 2014 May; 85(5):1068-77. PubMed ID: 24284520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipocytes do not significantly contribute to plasma angiotensinogen.
    Koizumi M; Niimura F; Fukagawa M; Matsusaka T
    J Renin Angiotensin Aldosterone Syst; 2016; 17(4):1470320316672348. PubMed ID: 28952396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis.
    Lu H; Balakrishnan A; Howatt DA; Wu C; Charnigo R; Liau G; Cassis LA; Daugherty A
    Br J Pharmacol; 2012 Mar; 165(6):2000-2008. PubMed ID: 22014125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of angiotensin type 2 receptor rescues obesity but not hypertension induced by overexpression of angiotensinogen in adipose tissue.
    Yvan-Charvet L; Massiéra F; Lamandé N; Ailhaud G; Teboul M; Moustaid-Moussa N; Gasc JM; Quignard-Boulangé A
    Endocrinology; 2009 Mar; 150(3):1421-8. PubMed ID: 18948399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of hepatic angiotensinogen using chemically modified siRNAs results in significant and sustained blood pressure lowering in a rat model of hypertension.
    Olearczyk J; Gao S; Eybye M; Yendluri S; Andrews L; Bartz S; Cully D; Tadin-Strapps M
    Hypertens Res; 2014 May; 37(5):405-12. PubMed ID: 24335718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.